Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
Yi Luo, Alan R. Tall
Yi Luo, Alan R. Tall
Published February 15, 2000
Citation Information: J Clin Invest. 2000;105(4):513-520. https://doi.org/10.1172/JCI8573.
View: Text | PDF
Article Article has an altmetric score of 3

Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element

  • Text
  • PDF
Abstract

The cholesterol ester transfer protein (CETP) facilitates the transfer of HDL cholesterol esters from plasma to the liver. Transgenic mice expressing human CETP, controlled by its natural flanking region, increase expression of this gene in response to hypercholesterolemia. We established a CETP promoter-luciferase reporter assay in differentiated 3T3-L1 adipocytes to map the sterol upregulatory element. Promoter mutagenesis suggested that a direct repeat of a nuclear receptor binding sequence separated by 4 nucleotides (DR4 element, –384 to –399) was responsible for this activity. Using mice carrying normal or mutated promoter sequences, we confirmed the importance of this element for gene induction by dietary sterol. A gel retardation complex containing LXR/RXR was identified using the CETP DR4 element and adipocyte nuclear extracts. Both LXRα/RXRα and LXRβ/RXRα transactivated the CETP promoter via its DR4 element in a sterol-responsive fashion. Thus, the positive sterol response of the CETP gene is mediated by a nuclear receptor binding site that is activated by LXRs. That Cyp7a, the rate-limiting enzyme for conversion of cholesterol into bile acids in the liver, is also regulated by LXRα suggests that this class of nuclear receptor coordinates the regulation of HDL cholesterol ester catabolism and bile acid synthesis in the liver.

Authors

Yi Luo, Alan R. Tall

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
(a) Gel mobility shift analysis to identify the proteins that bind to th...
(a) Gel mobility shift analysis to identify the proteins that bind to the DR4 element in the CETP promoter. A 24-bp fragment containing the CETP DR4 (cpDR4) (–380 to –403) was labeled and incubated with nuclear extracts from differentiated 3T3-L1 adipocytes in the presence of excess F2 fragment (CETP DR4 half site) to abolish nonspecific factors binding to the DR4 half site. Various cold competitor fragments were included as indicated, and shifted bands were resolved in a 5% polyacrylamide gel. F6 consists of only the 5′ half site and spacing region of the DR4 element. M1–M5 mutations are shown in Figure 3b. The arrow indicates the P1 complex. (b) The protein complex binding to the CETP DR4 contains an LXR/RXR heterodimer. Gel shift experiments were carried out in the absence (lane 1) or presence of 2 μg polyclonal antibodies against LXRα/β, LXRα, or RXRα (lanes 2–4), or RORα (lane 5). The arrow indicates the P1 band. The bands supershifted by RXRα or LXR antibodies are indicated by thick arrows.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
69 readers on Mendeley
See more details